Truvestments Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Truvestments Capital’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.88K	Sell	96 -58	-38%	-$1.42K	﹤0.01%	1011
2025 Q4	$4.12K	Hold	154	–	–	﹤0.01%	829
2025 Q3	$4.1K	Sell	154 -163	-51%	-$4.21K	﹤0.01%	857
2025 Q2	$7.28K	Hold	317	–	–	﹤0.01%	690
2025 Q1	$9.19K	Sell	317 -33	-9%	-$1.05K	﹤0.01%	672
2024 Q4	$13K	Buy	350 +152	+77%	+$6.95K	﹤0.01%	564
2024 Q3	$9.61K	Buy	+198	New	+$8.69K	﹤0.01%	591

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Truvestments Capital's AMPH Position: Q1 2026 in Review

Truvestments Capital reduced its Amphastar Pharmaceuticals (AMPH) stake by 38% in Q1 2026, selling an estimated $1.42K and leaving 96 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Truvestments Capital first reported a position in AMPH in Q3 2024 and has held it in 7 quarters since. The position peaked at $13K in Q4 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Truvestments Capital held 96 shares of Amphastar Pharmaceuticals worth $1.88K as of Q1 2026.
Truvestments Capital sold 58 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.42K.
Amphastar Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1011 holding.
Truvestments Capital first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
Truvestments Capital's Amphastar Pharmaceuticals position peaked at $13K in Q4 2024.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.